Health Condition 1: G437- Chronic migraine without aura
Conditions
Interventions
Intervention1: Nil: Nil
Control Intervention1: Nil: Nil
Sponsors
Dr Reddys Laboratories Ltd
Eligibility
Inclusion criteria
Inclusion criteria: Adults diagnosed with migraine according to the International Classification of Headache Disorders, 3rd edition (ICHD-3) criteria Patients who have been prescribed and have used REN devices within the past 12 months
Exclusion criteria
Exclusion criteria: Patients with incomplete medical records Patients with other significant chronic pain disorders Pregnant or breastfeeding women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Demographic information of the study population Categorize and assess the types of migraines duration of migraine history and patient profiles Proportion of patients showing improvement in clinical signs and symptoms of migraine after using Nerivio Reduction in migraine medication regimen Timepoint: baseline to end of 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of Adverse Event following the use of NerivioTimepoint: Baseline to 12 months | — |
Countries
India
Contacts
Public ContactDr Sagar Katare
Dr Reddys Laboratories limited
Outcome results
None listed